News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
109,000 Results
Type
Article (4623)
Company Profile (26)
Press Release (104351)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (40703)
Career Advice (117)
Deals (7021)
Drug Delivery (21)
Drug Development (13246)
Employer Resources (15)
FDA (2499)
Job Trends (3335)
News (61705)
Policy (4268)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (351)
Accelerated approval (4)
Allergies (32)
Alliances (4670)
ALS (28)
Alzheimer's disease (256)
Antibody-drug conjugate (ADC) (55)
Approvals (2625)
Artificial intelligence (53)
Autoimmune disease (19)
Automation (5)
Bankruptcy (53)
Best Places to Work (2905)
BIOSECURE Act (2)
Biosimilars (28)
Biotechnology (16)
Bladder cancer (49)
Brain cancer (9)
Breast cancer (153)
Cancer (1026)
Cardiovascular disease (78)
Career advice (107)
Career pathing (2)
CAR-T (28)
CDC (4)
Cell therapy (100)
Cervical cancer (5)
Clinical research (12144)
Collaboration (201)
Company closure (1)
Compensation (117)
Complete response letters (4)
COVID-19 (386)
CRISPR (18)
C-suite (68)
Cystic fibrosis (15)
Data (1404)
Depression (24)
Diabetes (90)
Diagnostics (1093)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (32)
Drug pricing (36)
Drug shortages (1)
Duchenne muscular dystrophy (31)
Earnings (33125)
Editorial (8)
Employer branding (3)
Employer resources (13)
Events (14358)
Executive appointments (93)
FDA (3278)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (186)
Gene editing (37)
Generative AI (5)
Gene therapy (79)
GLP-1 (163)
Government (686)
Grass and pollen (2)
Guidances (293)
Healthcare (3342)
HIV (31)
Huntington's disease (5)
IgA nephropathy (19)
Immunology and inflammation (36)
Immuno-oncology (4)
Indications (23)
Infectious disease (435)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (22)
Intellectual property (21)
Interviews (16)
IPO (4483)
IRA (9)
Job creations (550)
Job search strategy (93)
JPM (7)
Kidney cancer (1)
Labor market (28)
Layoffs (120)
Leadership (2)
Legal (678)
Liver cancer (17)
Longevity (1)
Lung cancer (157)
Lymphoma (88)
Machine learning (4)
Management (5)
Manufacturing (86)
MASH (53)
Medical device (2516)
Medtech (2528)
Mergers & acquisitions (2705)
Metabolic disorders (238)
Multiple sclerosis (29)
NASH (4)
Neurodegenerative disease (36)
Neuropsychiatric disorders (17)
Neuroscience (457)
NextGen: Class of 2026 (901)
Non-profit (511)
Now hiring (4)
Obesity (91)
Opinion (28)
Ovarian cancer (34)
Pain (22)
Pancreatic cancer (31)
Parkinson's disease (41)
Partnered (4)
Patents (41)
Patient recruitment (45)
Peanut (13)
People (4808)
Pharmaceutical (3)
Pharmacy benefit managers (7)
Phase 1 (2856)
Phase 2 (5110)
Phase 3 (5119)
Pipeline (1838)
Policy (45)
Postmarket research (473)
Preclinical (922)
Press Release (5)
Prostate cancer (49)
Psychedelics (9)
Radiopharmaceuticals (43)
Rare diseases (133)
Real estate (699)
Recruiting (7)
Regulatory (3620)
Reports (13)
Research institute (289)
Resumes & cover letters (16)
Rett syndrome (5)
RNA editing (2)
RSV (18)
Schizophrenia (40)
Series A (23)
Series B (19)
Service/supplier (1)
Sickle cell disease (20)
Special edition (6)
Spinal muscular atrophy (32)
Sponsored (9)
Startups (377)
Stomach cancer (3)
Supply chain (7)
Tariffs (16)
The Weekly (10)
Vaccines (165)
Venture capital (11)
Weight loss (51)
Women's health (12)
Worklife (2)
Date
Today (23)
Last 7 days (86)
Last 30 days (334)
Last 365 days (6678)
2026 (339)
2025 (6745)
2024 (7136)
2023 (8390)
2022 (9456)
2021 (10000)
2020 (8988)
2019 (7616)
2018 (5870)
2017 (5190)
2016 (4537)
2015 (5929)
2014 (3670)
2013 (2500)
2012 (2628)
2011 (3194)
2010 (3259)
Location
Africa (94)
Alabama (10)
Arizona (29)
Asia (6085)
Australia (786)
California (2395)
Canada (620)
China (161)
Colorado (91)
Connecticut (114)
Delaware (102)
Europe (16483)
Florida (246)
Georgia (83)
Hawaii (1)
Idaho (10)
Illinois (191)
India (10)
Indiana (117)
Iowa (3)
Japan (129)
Kansas (18)
Kentucky (14)
Louisiana (11)
Maine (22)
Maryland (251)
Massachusetts (1502)
Michigan (43)
Minnesota (111)
Mississippi (1)
Missouri (22)
Montana (4)
Nebraska (1)
Nevada (21)
New Hampshire (20)
New Jersey (837)
New York (751)
North Carolina (286)
North Dakota (2)
Northern California (1237)
Ohio (47)
Oklahoma (3)
Oregon (5)
Pennsylvania (479)
Puerto Rico (1)
Rhode Island (6)
South America (147)
South Carolina (5)
Southern California (934)
Tennessee (22)
Texas (282)
United States (8260)
Utah (157)
Virginia (35)
Washington D.C. (12)
Washington State (175)
Wisconsin (14)
Wyoming (1)
109,000 Results for "35".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
The facility, which is part of Lilly’s $50 billion reshoring drive, will make obesity drugs such as tirzepatide and retatrutide when it starts operations in 2031.
February 2, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
January 9, 2026
·
6 min read
Press Releases
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
January 12, 2026
·
4 min read
Press Releases
ABK Biomedical Raises US$35M in Series D Financing
October 15, 2025
·
3 min read
Press Releases
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
January 14, 2026
·
5 min read
Press Releases
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening Platform
December 1, 2025
·
4 min read
Press Releases
Stem Cell Banking Market to Worth USD 35.12 Billion, Forecasts 16.14% CAGR by 2034
October 22, 2025
·
1 min read
Press Releases
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
October 1, 2025
·
6 min read
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in late-stage development for metabolic dysfunction-associated steatohepatitis.
September 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025
October 8, 2025
·
4 min read
1 of 10,900
Next
